日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

司库奇尤单抗治疗与银屑病、银屑病关节炎或强直性脊柱炎患者结核病复发的相关性

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2020.3257
Elewski, Boni E; Baddley, John W; Deodhar, Atul A; Magrey, Marina; Rich, Phoebe A; Soriano, Enrique R; Soung, Jennifer; Bao, Weibin; Keininger, Dorothy; Marfo, Kwaku; Patekar, Manmath; Sharma, Abhishek; Shete, Abhijit; Lebwohl, Mark Gabriel
强直性脊柱炎
关节炎
银屑病
免疫/内分泌
发表日期：2021
文献求助 收藏

Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study

识别慢性阻塞性肺病患者肺炎的相关风险：ARCTIC 一项观察性研究

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-018-0868-y
Janson, Christer; Johansson, Gunnar; Ställberg, Björn; Lisspers, Karin; Olsson, Petter; Keininger, Dorothy L; Uhde, Milica; Gutzwiller, Florian S; Jörgensen, Leif; Larsson, Kjell
肺炎
ARC
发表日期：2018
文献求助 收藏

Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey

影响慢性阻塞性肺病患者正确使用吸入器的因素——来自REAL调查的启示

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S149404
Price, David; Keininger, Dorothy L; Viswanad, Boomi; Gasser, Matthias; Walda, Susann; Gutzwiller, Florian S
发表日期：2018
文献求助 收藏

Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population

在慢性阻塞性肺疾病（COPD）治疗中，与沙美特罗/氟替卡松相比，茚达特罗/格隆溴铵具有成本效益：基于FLAME模型的瑞典人群研究

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-017-0688-5
Bjermer, Leif; van Boven, Job F M; Costa-Scharplatz, Madlaina; Keininger, Dorothy L; Gutzwiller, Florian S; Lisspers, Karin; Mahon, Ronan; Olsson, Petter; Roche, Nicolas
COPD
慢性阻塞性肺疾病
发表日期：2017
文献求助 收藏

Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study

更正：英国基层医疗中慢性阻塞性肺疾病初始治疗选择随时间的变化及影响处方决策的因素：一项真实世界研究

期刊:npj Primary Care Respiratory Medicine
影响因子:4.7
doi:10.1038/npjpcrm.2017.4
Gruffydd-Jones, Kevin; Brusselle, Guy; Jones, Rupert; Miravitlles, Marc; Baldwin, Michael; Stewart, Rebecca; Rigazio, Anna; Davis, Emily; Keininger, Dorothy L; Price, David
慢性阻塞性肺疾病
发表日期：2017
文献求助 收藏

Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational

英国初级保健中慢性阻塞性肺疾病初始治疗选择随时间的变化及影响处方决策的因素：一项真实世界的回顾性观察研究

期刊:npj Primary Care Respiratory Medicine
影响因子:4.7
doi:10.1038/npjpcrm.2016.2
Gruffydd-Jones, Kevin; Brusselle, Guy; Jones, Rupert; Miravitlles, Marc; Baldwin, Michael; Stewart, Rebecca; Rigazio, Anna; Davis, Emily; Keininger, Dorothy L; Price, David
慢性阻塞性肺疾病
发表日期：2016
文献求助 收藏

The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK

慢性阻塞性肺病治疗中三联疗法的必然趋势：英国处方路径分析

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S91694
Brusselle, Guy; Price, David; Gruffydd-Jones, Kevin; Miravitlles, Marc; Keininger, Dorothy L; Stewart, Rebecca; Baldwin, Michael; Jones, Rupert C
发表日期：2015
文献求助 收藏

Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease

塞妥珠单抗聚乙二醇（Certolizumab pegol）是一种每月一次皮下注射的无Fc片段抗TNFα药物，可改善中重度克罗恩病患者的健康相关生活质量。

期刊:International Journal of Colorectal Disease
影响因子:2.3
doi:10.1007/s00384-007-0395-7
Rutgeerts, Paul; Schreiber, Stefan; Feagan, Brian; Keininger, Dorothy L; O'Neil, Liz; Fedorak, Richard N
克罗恩病
TNFα
发表日期：2008
文献求助 收藏